Nom du produit:N-[4-bromo-2-(3-oxo-3,4-dihydroquinoxalin-2-yl)phenyl]-4-methylbenzene-1-sulfonamide

IUPAC Name:N-[4-bromo-2-(3-oxo-3,4-dihydroquinoxalin-2-yl)phenyl]-4-methylbenzene-1-sulfonamide

CAS:899350-92-6
Formule moléculaire:C21H16BrN3O3S
Pureté:95%+
Numéro de catalogue:CM992087
Poids moléculaire:470.34

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:899350-92-6
Formule moléculaire:C21H16BrN3O3S
Point de fusion:-
Code SMILES:CC1=CC=C(C=C1)S(=O)(=O)NC1=C(C=C(Br)C=C1)C1=NC2=C(NC1=O)C=CC=C2
Densité:
Numéro de catalogue:CM992087
Poids moléculaire:470.34
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.